R9Z Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ImmuneOnco Biopharmaceuticals Shanghai Inc

Watchlist Manager

Watchlist

Price: 0.386 EUR -0.52%

Market Cap: €166.6m

	ImmuneOnco Biopharmaceuticals Shanghai Inc F:R9Z	CN
	Showa System Engineering Corp TSE:4752	JP
	Jiangsu General Science Technology Co Ltd SSE:601500	CN
	Battery Minerals Ltd ASX:BAT	AU
L	Levantina de Edificacion y Obras Publicas SA Cia MAD:CLEO	ES
	Compagnie Plastic Omnium SE PAR:OPM	FR
	Bank of Southside Virginia OTC:BSSC	US
	Pyramid AG F:M3B0	DE
	Troc de l Ile SA PAR:MLTRO	FR
C	China Vanadium Titano Magnetite Mining Co Ltd XMUN:CV8S	HK
	DX (Group) PLC F:4DX	UK
	Interact-TV Inc OTC:ITVI	US

Profitability Summary

ImmuneOnco Biopharmaceuticals Shanghai Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Sustainable 3Y Average Gross Margin

33%

Negative Operating Margin

-138%

Negative 3Y Average Operating Margin

-277%

Negative Net Margin

-142%

Negative 3Y Average Net Margin

-279%

Negative Free Cash Flow Margin

-132%

Negative 3Y Average Free Cash Flow Margin

-148%

Negative ROE

-30%

Negative 3Y Average ROE

-43%

Negative ROIC

-657%

Negative 3Y Average ROIC

-512%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.